Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 1 Year to 12

Ciprofol and Fentanyl for LMA Insertion in Children: Finding the ED95 Dose

Official title: The ED95 of Ciprofol for Laryngeal Mask Airway Insertion With Fentanyl in Children: A Biased-Coin Dose-Finding Trial

Run by Huazhong University of Science and Technology · NCT07697404 · Data updated 2026-11-12

This study tests the smallest effective single dose of ciprofol, given with fentanyl, to help placing a laryngeal mask airway in children aged 1–12 undergoing anesthesia.

More Pediatric Cancer trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages1 Year to 12 Years
SexAll
Enrollment180 (estimated)
SponsorHuazhong University of Science and Technology
Academic / other
Locations1 site (Wuhan, Hubei)
StatusRecruiting
StartedJune 15, 2026
Main results expectedJuly 2, 2028
Study endsDecember 1, 2028
Registry record updatedJuly 13, 2026
Trial IDNCT07697404 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children 1–12 years old, ASA I–II, scheduled for elective surgery requiring LMA insertion and able to tolerate IV cannulation.

Probably not a fit

Patients with difficult airways, obesity (BMI outside 15–30), or contraindications to ciprofol or fentanyl may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-blind, biased-coin dose-finding trial aims to identify the ED95 of a single IV bolus of ciprofol when used with a fixed fentanyl dose (1 μg/kg) for LMA insertion during pediatric anesthesia induction. 180 ASA I–II children aged 1–12 years are enrolled and divided into three age groups (1–3, 4–6, 7–12) of 60 each. Ciprofol is administered over 1 minute with up-down biased-coin dosing to adjust the next patient's dose based on the prior outcome. LMA insertion is attempted 90 seconds after drug administration and assessed for movement, jaw tightness, coughing, gagging, or laryngospasm. The design preserves blinding for the evaluator and the LMA inserter while the administering anesthesiologist knows the dose. Primary outcomes focus on successful LMA insertion without adverse responses.

Why it matters

Potential benefit: If successful, the study could identify an optimal ciprofol dose to improve LMA insertion conditions with fewer side effects in children.

How similar studies have gone: Previous anesthetic dosing studies in children support dose-finding designs; this particular biased-coin up-down approach with ciprofol is novel in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* American Society of Anesthesiologists (ASA) physical status I or II
* Aged 1 to 12 years
* Scheduled for elective surgery requiring general anesthesia with laryngeal mask airway (LMA) insertion (e.g., ophthalmic surgery, skin lesion excision, minor abdominal or urological procedures, with expected surgical duration ≤ 2 hours)
* Written informed consent obtained from parents or legal guardians

Exclusion Criteria:

* Known allergy or hypersensitivity to ciprofol, fentanyl, or any study-related drugs
* Intellectual disability, cognitive-affective disorders, psychiatric or neurological diseases
* Inability to cooperate with peripheral intravenous cannulation
* History of reactive airway disease or suspected difficult airway
* Body mass index (BMI) ≥ 30 kg/m² or ≤ 15 kg/m²
* History of sedative medication use
* Inability to understand the study protocol or participation in another clinical trial within the past 30 days

Where it's running

  • Tongji Hospital
    Wuhan, Hubei, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.